Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Regulatory Toxicology and Pharmacology : RTP|August 31, 2025
Evaluation of good review practices at the Food and Drugs Authority of Ghana as it strives to become a World Health Organization-listed agencyMercy Owusu-Asante, Delese Mimi Darko, Seth Seaneke, et al.
Therapeutic Innovation & Regulatory Science|October 26, 2023
An Evaluation of the Swissmedic Regulatory Framework for New Active SubstancesMagda Bujar, Simon Andreas Dalla Torre di Sanguinetto, Adem Kermad, et al.
Frontiers in Pharmacology|April 20, 2017
FDA Facilitated Regulatory Pathways: Visualizing Their Characteristics, Development, and Authorization TimelinesLawrence Liberti, Magda Bujar, Alasdair Breckenridge, et al.
International Journal of Technology Assessment in Health Care|April 11, 2023
Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursementTing Wang, Neil McAuslane, Wim G Goettsch, et al.
Therapeutic Innovation & Regulatory Science|September 1, 2020
An Evaluation of Malaysian Regulatory Process for New Active Substances Approved in 2017 Using the OpERA MethodologyNoraisyah Mohd Sani, Neil McAuslane, Siti Hidayah Kasbon, et al.
Therapeutic Innovation & Regulatory Science|September 1, 2020
Correction to: An Evaluation of Malaysian Regulatory Process for New Active Substances Approved in 2017 Using the OpERA MethodologyNoraisyah Mohd Sani, Neil McAuslane, Siti Hidayah Kasbon, et al.
Journal of Public Health Policy|March 11, 2016
Accelerating access to new medicines: Current status of facilitated regulatory pathways used by emerging regulatory authoritiesLawrence Liberti, Alasdair Breckenridge, Jarno Hoekman, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Characterizing Good Review Practices: A Survey Report Among Agencies of APEC Member EconomiesLi-Ling Liu, Neil McAuslane, Meir-Chyun Tzou, et al.
Frontiers in Medicine|October 9, 2025
Harmonizing health: a global analysis of pharmaceutical regulatory activities by international regulatory organizationsAgnes Dangy-Caye, Alice Mousset, Adem Kermad, et al.
Pageof 5